Singapore-based entities continue to report significant shareholding changes in Hypersoft Technologies following a major preferential allotment of equity shares. The company has now received formal listing approval from BSE Limited for the 6,82,00,000 equity shares issued on preferential basis, marking a significant milestone in the capital restructuring process.

BSE Listing Approval Details

BSE Limited granted listing approval for the preferential allotment through letter reference no. LOD/PREF/PR/FIP/1823/2025-26 dated March 06, 2026. The approval covers 6,82,00,000 equity shares of Rs. 10/- each issued at a premium of Rs. 19.25/- to both promoters and non-promoters.

Regulatory Compliance Requirements

The exchange has outlined specific compliance requirements for trading approval. The company must file confirmation letters from NSDL/CDSL regarding crediting shares to beneficiary accounts and admitting capital to the depository system. Additionally, BSE has mandated filing of shareholding pattern in XBRL mode as the change exceeds two percent of total paid-up share capital.

Impact on Singapore-based Shareholders

The listing approval validates the shareholding changes previously reported by Singapore entities. Cyberpath Systems Pte. Ltd. emerged as the largest new stakeholder with 1,36,00,000 shares representing 16.10% ownership, while existing shareholders Vertexiq Pte. Ltd. and Valueforge Innovations Pte. Ltd. experienced significant dilution.

Share Capital Transformation

The preferential allotment fundamentally expanded Hypersoft Technologies' equity base from Rs. 16,25,17,000 to Rs. 84,45,17,000. The company's total share count increased from 1,62,51,700 to 8,44,51,700 shares, representing a substantial capital infusion.

Next Steps and Trading Timeline

Hypersoft Technologies must complete remaining regulatory formalities within specified timelines to enable trading of the newly allotted shares. The company has seven working days from the listing approval date to apply for trading approval, with potential penalties for non-compliance as per SEBI circular dated June 21, 2023.

Hypersoft Technologies has witnessed significant shareholding changes following its preferential share allotment, with multiple entities acquiring substantial stakes. The company's Board of Directors approved the transaction on February 27, 2026, following in-principle approval from BSE Limited received on February 23, 2026.

Preferential Share Allotment Overview

The company executed a preferential allotment of 6.82 crore equity shares with a face value of Rs. 10.00 each, priced at Rs. 29.25 per share. The transaction was structured as a share swap arrangement rather than a cash consideration deal.

Quotrix Solutions' Substantial Acquisition

Quotrix Solutions Pte. Ltd., a Singapore-based entity, has disclosed substantial acquisition of shares under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company submitted its disclosure to BSE Limited on March 4, 2026.

Complete Share Distribution Among Allottees

The preferential allotment was distributed among four entities as part of the acquisition structure:

Impact on Share Capital Structure

The preferential allotment significantly expanded the company's equity base and resulted in substantial dilution of existing shareholdings:

Strategic Acquisition and Subsidiary Structure

Through this share swap arrangement, Hypersoft Technologies acquired 6.82 crore shares of Nexus Innovate Pte. Ltd., making it a wholly owned subsidiary. The acquisition also resulted in Nexus Innovate LLC becoming a wholly owned step-down subsidiary, as it was previously a wholly owned subsidiary of Nexus Innovate Pte. Ltd.

Regulatory Compliance

The transaction was completed in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Quotrix Solutions' disclosure under Regulation 29(1) of SEBI Takeover Regulations demonstrates adherence to proper regulatory compliance and transparency requirements.